Financials Alpha Tau Medical Ltd.

Equities

DRTS

IL0011839383

Investment Holding Companies

Market Closed - Nasdaq 16:30:00 2024-05-15 EDT 5-day change 1st Jan Change
2.65 USD +0.61% Intraday chart for Alpha Tau Medical Ltd. +9.96% -11.96%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 337.6 219.5 209.1 184.6 - -
Enterprise Value (EV) 1 337.6 219.5 209.1 184.6 184.6 184.6
P/E ratio - - - - - -
Yield - - - - - -
Capitalization / Revenue - - - 2,462 x 134 x 9.17 x
EV / Revenue - - - 2,462 x 134 x 9.17 x
EV / EBITDA - -7.04 x -6.04 x -4.06 x -3.26 x -6.94 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 34,375 69,012 69,474 69,671 - -
Reference price 2 9.820 3.180 3.010 2.650 2.650 2.650
Announcement Date 22-03-28 23-03-09 24-03-07 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - - - 0.075 1.373 20.13
EBITDA 1 - -31.16 -34.61 -45.49 -56.58 -26.6
EBIT 1 -13.79 -32.14 -35.68 -41.42 -52.13 -46.9
Operating Margin - - - -55,220.48% -3,795.87% -232.96%
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS - - - - - -
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 22-03-28 23-03-09 24-03-07 - - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 - - - - - - - - - - 0.025 0.05 0.3
EBITDA 1 - - - - - - - - -10.14 -10.7 -11.34 -12.08 -
EBIT 1 -8.781 -8.012 -7.358 -7.985 -8.644 -8.168 -7.339 -9.943 -9.814 -9.838 -10.49 -11.27 -11.78
Operating Margin - - - - - - - - - - -41,943.32% -22,549.72% -3,928%
Earnings before Tax (EBT) - - - - - - - - - - - - -
Net income - - - - - - - - - - - - -
Net margin - - - - - - - - - - - - -
EPS - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 22-05-26 22-08-25 22-11-22 23-03-09 23-05-23 23-08-28 23-11-16 24-03-07 - - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - -95.3% - -45.8% -44.2% -8.72%
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 2.93 0.9 - 4 6 -
Capex / Sales - - - 5,333.33% 436.89% -
Announcement Date 22-03-28 23-03-09 24-03-07 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.65 USD
Average target price
9.25 USD
Spread / Average Target
+249.06%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DRTS Stock
  4. Financials Alpha Tau Medical Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW